Skip to main content
Clinical Trials/ACTRN12617000951358
ACTRN12617000951358
Active, not recruiting
Phase 2

ymph node grafting for upper limb lymphoedema following breast cancer treatment

Mr Winston McEwan0 sites65 target enrollmentJuly 4, 2017

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Mr Winston McEwan
Enrollment
65
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 4, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Mr Winston McEwan

Eligibility Criteria

Inclusion Criteria

  • 1\) Ipsilateral upper limb lymphoedema of severity stage one (but requiring the regular use of a compression garment) or stage two (ISL staging system).
  • 2\) Meets definition of lymphoedema: has either a 200 ml inter\-limb volume difference, or a 10% difference in limb volume.
  • 3\) Previously treated stage 1\-3 breast cancer.
  • 4\) Undergone local standard lymphoedema therapy for at least three months prior to enrolment and continued participation with techniques.
  • 5\) Fit for operative procedure.

Exclusion Criteria

  • 1\) Metastatic breast cancer;
  • 2\) Past history of other malignancy with potential lymphatic drainage to either axillae;
  • 3\) BMI \>40;
  • 4\) Current smoker;
  • 5\) Congestive heart failure;
  • 6\) low serum albumin (\<32g/L);
  • 7\) Poorly controlled diabetes (bA1c \> 70mm/L);
  • 8\) Steroid medication;
  • 9\) Previous lymph node grafting.

Outcomes

Primary Outcomes

Not specified

Similar Trials